| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.67B | 52.65B | 44.54B | 38.24B | 30.25B | 25.39B |
| Gross Profit | 20.75B | 23.87B | 19.46B | 16.34B | 12.76B | 10.82B |
| EBITDA | 6.99B | 7.53B | 6.62B | 5.72B | 4.21B | 3.01B |
| Net Income | 3.54B | 3.46B | 3.39B | 3.15B | 2.08B | 2.32B |
Balance Sheet | ||||||
| Total Assets | 37.10B | 47.06B | 33.21B | 30.65B | 22.16B | 17.16B |
| Cash, Cash Equivalents and Short-Term Investments | 3.44B | 3.56B | 3.01B | 3.74B | 4.33B | 3.89B |
| Total Debt | 15.05B | 22.75B | 12.19B | 13.27B | 9.04B | 7.71B |
| Total Liabilities | 22.54B | 30.61B | 18.98B | 19.30B | 14.01B | 10.92B |
| Stockholders Equity | 14.56B | 16.45B | 14.23B | 11.34B | 8.16B | 6.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -8.27B | 1.78B | -4.09B | 363.00M | 787.00M |
| Operating Cash Flow | 0.00 | 4.95B | 5.20B | 4.61B | 3.77B | 2.92B |
| Investing Cash Flow | 0.00 | -13.17B | -4.10B | -8.77B | -5.00B | -2.13B |
| Financing Cash Flow | 0.00 | 8.77B | -1.83B | 3.55B | 1.66B | 438.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥822.75B | 17.65 | 7.70% | 2.67% | -2.65% | 0.31% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥78.28B | 41.10 | ― | 0.65% | 18.22% | 2.33% | |
61 Neutral | ¥56.01B | 81.78 | ― | 0.60% | 4.70% | 10.83% | |
58 Neutral | ¥585.74B | -160.87 | -12.76% | 1.77% | 0.52% | -1385.51% | |
57 Neutral | ¥300.04B | -9.09 | 8.17% | 1.49% | ― | ― | |
50 Neutral | ¥82.17B | -0.63 | ― | 1.01% | 1.71% | -890.78% |